Ju Wang

AlphaFold Accelerates Artificial Intelligence Powered Drug Discovery: Efficient Discovery of a Novel Cyclin-dependent Kinase 20 (CDK20) Small Molecule Inhibitor

M. Levitt, Alán Aspuru-Guzik, A. Aliper, 2022, ArXiv.

Identification of Therapeutic Targets for Amyotrophic Lateral Sclerosis Using PandaOmics – An AI-Enabled Biological Target Discovery Platform

A. Aliper, J. Rothstein, M. Cudkowicz, 2022, Frontiers in Aging Neuroscience.

Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery engine

A. Aliper, A. Zhavoronkov, J. de Magalhães, 2022, Aging.

AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitor

Wei Zhu, Alán Aspuru-Guzik, A. Aliper, 2023, Chemical science.

Discovery of Potent, Selective, and Orally Bioavailable Small-Molecule Inhibitors of CDK8 for the Treatment of Cancer.

A. Zhavoronkov, Xiao Ding, Yingtao Liu, 2023, Journal of medicinal chemistry.

AlphaFold Accelerates Artificial Intelligence Powered Drug Discovery: Efficient Discovery of a Novel Cyclin-dependent Kinase 20 (CDK20) Small Molecule Inhibitor

Alan Aspuru-Guzik, Vladimir Aladinskiy, Alex Zhavoronkov, 2022 .

Supporting

Wei Zhu, Alán Aspuru-Guzik, I. Ozerov, 2020, Encyclopedia of Autism Spectrum Disorders.